10:00 am – 10:09 am:  Principles in the Pathogenesis of Inherited Retinal Diseases: Focus on Inflammation.  Paul Yang, MD, PhD

10:09 am – 10:18 am:  Updates on Gene Therapy for Retinal Diseases: What Are the Challenges?  David Almeida, MD, MBA, PhD

10:18 am – 10:27 am:  Current Understanding  of Immunogenicity in Adeno-Associated Virus Based Retinal Gene Therapy.  Victor Chong, MD, MBA

10:27 am – 10:36 am:  Intravitreal AAV Gene Therapy: Review of 2024 Data and Thoughts on Future Directions.  Stephen Smith, MD

10:36 am – 10:45 am:  Where Should Be the Next Inflammatory Target for AMD and DME?  David Eichenbaum, MD

10:45 am – 10:54 am:  Update on Intraocular Inflammation Secondary to More Durable Intravitreal Agents.  Ramsudha Narala, MD

10:54 am – 11:03 am:  Oral Medications for Retinal Disease.  Charles DeBoer, MD, PhD

11:03 am – 11:30 am:  Panel Discussion